Grupo Español De Enfermedades Mieloproliferativas Crónicas Ph Negativas

This study is testing whether the drug pacritinib can reduce scarring (fibrosis) in the bone marrow of patients with myelofibrosis who also have low platelet counts. Thirty participants will take pacritinib for up to two years, with regular check-ups to see if the drug improves b…